Spartalizumab, CAS 1935694-88-4

Product Description: Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Jaume Capdevila, et al. PD-1 Blockade in Anaplastic Thyroid Carcinoma. J Clin Oncol. 2020 Aug 10;38(23):2620-2627.

CAS Number: 1935694-88-4

Molecular Weight: N/A

Compound Purity: 98.40

Research Area: Cancer

Solubility: H2O

Target: PD-1/PD-L1

• SKU: MEXHY-P9972-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9972-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated